Fluorescent quantum defects in single-wall carbon nanotubes (SWCNTs) are a major advance in nanocarbon research, owing to their bright, single-photon emission at telecom wavelengths and versatile conjugation chemistries for biomedical sensing and disease targeting. Here, we introduce an efficient, oxygen-free sonochemical route that generates long-chain alkyl defects, simultaneously shortening nanotubes and producing a bright, homogeneously emissive (6,5) SWCNT ensemble. Among 15 screened surfactants and initiators, the branched-chain Niaproof ® 4, which molecular dynamics simulations show packs more densely and uniformly than linear surfactants, yields a 3.4-fold brightness enhancement and a sharp emission peak near 1108 nm. Single-particle spectroscopy reveals J-aggregate emission redshifts at high defect densities, and fibrinogen titration shows defect chemistry governs protein-driven coating displacement. Using a home-built short-wave infrared imaging system (25 mW cm −2 , 989 nm excitation, 1150 nm longpass collection), we show that these sparse defects (~15.2 μm −1 ) drive different, nonmonotonic pharmacokinetics between Niaproof ® 4– and lipid-PEG–functionalized (6,5) at early time points, converging as protein-corona formation masks the underlying chemistry. Histology localizes the nanotubes within macrophages of mononuclear phagocyte system–associated organs. Intravenous administration (50 μg kg −1 ) shows no acute toxicity and short ~2-day retention, while the Niaproof ® 4 group depletes more myeloid cells after corona formation.